Pharmacotherapy of diabetes mellitus and its economic consequences in the Slovak Republic

Journal of Social and Administrative Pharmacy

Volumn 20, Issue 2, 2003, Pages 77-79

  Foltan, Viliam ^a   Palágyi, Michaela ^a   Tesar, Tomas ^a  

^a Faculty of Natural Sciences   (Slovakia)

Author keywords

Cinical diabetes; Consumption; Diabetes mellitus; Insulin; Oral antidiabetics

Indexed keywords

ACARBOSE; BIGUANIDE DERIVATIVE; INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ARTICLE; CHRONIC DISEASE; DRUG MARKETING; DRUG UTILIZATION; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SLOVAKIA;

EID: 0038136711     PISSN: 02810662     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Michalek J. Pharmacoeconomic of treatment diabetes mellitus 1. Type, conference Pharmacoeconomic in the Slovak Republic 2, Bratislava, jan 2002.
2. Kriska M et al. Memorix of clinical pharmacology, Slovak Academic Press, s.r.o., Bratislava,2002;218-223.
3. Martinka E. Conference Pharmacoeconomic in the Slovac Republik 2, Bratislava, jan 2002.
4. Foltan V, Cintala J. Drug policy and reflexion in the consumption of drug in the Slovak Republic, Association of pharmaceutical producers SR, 2001;104.
5. Foltan V, Tesar T, Stara D. Evaluation of Bioavailability of Drugs in European Union - database SIDC. Farmaceuticky Obzor 2002;3:51-55.
6. Foltan V. Database of the Slovak Institute for Drug Control (SIDC) from the period 1996-2002.